Organization
Centre for Cancer Biomarkers CCBIO
3 abstracts
Abstract
Rapid label expansion based on public-private collaboration in IMPRESS-Norway.Org: Oslo University Hospital-Norwegian Radium Hospital, Department of Cancer Immunology, The Arctic University of Norway, Centre for Cancer Biomarkers CCBIO,
Abstract
BORTEM-17: A phase IB/II single arm, multicentre study investigating the efficacy of sequential bortezomib and temozolomide in recurrent GBM with unmethylated MGMT promoter—The results of an interim analysis.Org: Haukeland University Hospital, Department of Oncology and Haematology, Division of Oncology, University Hospital of Modena, Modena, Italy, Bergen, Norway, Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway, Oslo University Hospital, Division of Cancer Medicine, Oslo, Norway,
Abstract
A prospective non-randomized phase I trial of dendritic cell–based cryoimmunotherapy combined with checkpoint inhibitors in mCRPC.Org: Centre for Cancer Biomarkers CCBIO, University of Bergen, Dept. of Urology, Haukeland University Hospital, Dept. of Pathology,